Biocept to Present at the LD Micro Main Event on October 13
06 Outubro 2021 - 9:00AM
Business Wire
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular
diagnostic assays, products and services, announces that Michael
Nall, President and CEO, will present a company overview at the LD
Micro Main Event on Wednesday, October 13, 2021 at 11:00 a.m.
Pacific time (2:00 p.m. Eastern time). The conference is being held
at the Luxe Sunset Boulevard Hotel in Los Angeles.
A pre-recorded webcast of the presentation will be available on
the Events and Presentations page of the company website beginning
October 13 at 11:00 a.m. Pacific time.
About Biocept
Biocept, Inc., develops and commercializes molecular diagnostic
assays that provide physicians with clinically actionable
information to aid in the diagnosis, treatment and monitoring of
patients with cancer. In addition to its broad portfolio of
blood-based liquid biopsy tests, the company has developed the
CNSideTM cerebrospinal fluid assay, designed to diagnose cancer
that has metastasized to the central nervous system. Biocept also
is leveraging its molecular diagnostic capabilities to offer
nationwide RT-PCR-based COVID-19 testing and services to support
public health efforts during this unprecedented pandemic. For more
information, visit www.biocept.com. Follow Biocept on Facebook,
LinkedIn and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211006005352/en/
Investors Jody Cain, LHA Investor Relations
Jcain@lhai.com, 310-691-7100
Media Andrea Sampson, Sampson PR Group
asampson@sampsonprgroup.com, 562-304-0301
Biocept (NASDAQ:BIOC)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Biocept (NASDAQ:BIOC)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
